Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01803113 · ClinicalTrials.gov registry record
Sofia hCG FIA Field Study
A clinical trial of Pregnancy, Early Detection, sponsored by Quidel Corporation.
- Completed
- Registry status
- 975
- Enrollment target
- 5
- Study locations
NCT01803113 is a study of Pregnancy, Early Detection that has completed, run by Quidel Corporation. The registered enrollment target is 975 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT01803113, a study of Pregnancy, Early Detection, has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 975 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.
Conditions Studied
Interventions
- DEVICE Sofia hCG FIA
Study Locations (5)
Massachusetts
- NECCR of Massachusetts, LLC - Fall River
- New England Center for Clinical Research Fall River,LLC (NECCR) - Fall River
Florida
- Jose Castaneda, MD - Boynton Beach
Rhode Island
- Partners In Obstetrics and Gynecology, Inc. - Pawtucket
Texas
- Planned Parenthood Gulf Coast - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 975 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01803113
The ClinicalTrials.gov registry entry for NCT01803113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 975 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy, Early Detection appearing as the primary indexed condition, and to 1 intervention - of which Sofia hCG FIA is the first listed.
NCT01803113 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Florida, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01803113 about?
NCT01803113 is a clinical study titled "Sofia hCG FIA Field Study". The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.
What is the current status of trial NCT01803113?
This trial is currently completed. The enrollment target is 975 participants. The study started on 2013-01. Estimated completion is 2013-03.
What conditions does trial NCT01803113 study?
This clinical trial studies the following conditions: Pregnancy, Early Detection.
What interventions are being tested in trial NCT01803113?
The interventions under investigation include: Sofia hCG FIA (DEVICE).
Who is sponsoring clinical trial NCT01803113?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01803113 being conducted?
This trial has 5 study locations across Florida, Massachusetts, Rhode Island, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.